Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2015

Open Access 01-12-2015 | Research article

The association of alcohol consumption with mammographic density in a multiethnic urban population

Authors: Zoe Quandt, Julie D Flom, Parisa Tehranifar, Diane Reynolds, Mary Beth Terry, Jasmine A McDonald

Published in: BMC Cancer | Issue 1/2015

Login to get access

Abstract

Background

Alcohol consumption is associated with higher breast cancer risk. While studies suggest a modest association between alcohol intake and mammographic density, few studies have examined the association in racial/ethnic minority populations.

Methods

We assessed dense breast area and total breast area from digitized film mammograms in an urban cohort of African American (42%), African Caribbean (22%), white (22%), and Hispanic Caribbean (9%) women (n = 189, ages 40-61). We examined the association between alcohol intake and mammographic density (percent density and dense area). We used linear regression to examine mean differences in mammographic density across alcohol intake categories. We considered confounding by age, body mass index (BMI), hormone contraceptive use, family history of breast cancer, menopausal status, smoking status, nativity, race/ethnicity, age at first birth, and parity.

Results

Fifty percent currently consumed alcohol. Women who consumed >7 servings/week of alcohol, but not those consuming ≤7 servings/week, had higher percent density compared to nondrinkers after full adjustments (servings/week >7 β = 8.2, 95% Confidence Interval (CI) 1.8, 14.6; ≤7 β = -0.5, 95% CI -3.7, 2.8). There was a positive association between high alcohol intake and dense area after full adjustments (servings/week >7 β = 5.8, 95% CI -2.7, 14.2; ≤7 β = -0.1, 95% CI -4.4, 4.2). We did not observe race/ethnicity modification of the association between alcohol intake and percent density. In women with a BMI of <25 kg/m2, drinkers consuming >7 servings/week of alcohol had a 17% increase in percent density compared to nondrinkers (95% CI 5.4, 29.0) and there was no association in women with a BMI ≥ 25 kg/m2 (BMI ≥ 25-30 kg/m2 > 7 β = 5.1, 95% CI -8.5, 18.7 and BMI > 30 kg/m2 > 7 β = 0.5, 95% CI -6.5, 7.5) after adjusting for age and BMI (continuous).

Conclusion

In a racially/ethnically diverse cohort, women who consumed >7 servings/week of alcohol, especially those with a BMI < 25 kg/m2, had higher percent density.
Literature
1.
Singletary K, Nelshoppen J, Wallig M. Enhancement by chronic ethanol intake of N-methyl-N-nitrosourea-induced rat mammary tumorigenesis. Carcinogenesis. 1995;16(4):959–64.CrossRefPubMed
2.
Martin LJ, Boyd NF. Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res. 2008;10(1):201.CrossRefPubMedPubMedCentral
3.
Prevention. CfDCa. Prevalence of Coronary Heart Disease - United States, 2006-2010. Morb Mortal Wkly Rep. 2011;60(40):1377–81.
4.
Allen NE, Beral V, Casabonne D, Kan SW, Reeves GK, Brown A, et al. Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst. 2009;101(5):296–305.CrossRefPubMed
5.
Gapstur SM, Lopez P, Colangelo LA, Wolfman J, Van Horn L, Hendrick RE. Associations of breast cancer risk factors with breast density in Hispanic women. Cancer Epidemiol Biomarkers Prev. 2003;12(10):1074–80.PubMed
6.
Brisson J, Verreault R, Morrison AS, Tennina S, Meyer F. Diet, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol. 1989;130(1):14–24.PubMed
7.
Maskarinec G, Pagano I, Chen Z, Nagata C, Gram IT. Ethnic and geographic differences in mammographic density and their association with breast cancer incidence. Breast Cancer Res Treat. 2007;104(1):47–56.CrossRefPubMed
8.
Flom JD, Ferris JS, Tehranifar P, Terry MB. Alcohol intake over the life course and mammographic density. Breast Cancer Res Treat. 2009;117(3):643–51.CrossRefPubMedPubMedCentral
9.
Masala G, Ambrogetti D, Assedi M, Giorgi D, Del Turco MR, Palli D. Dietary and lifestyle determinants of mammographic breast density. A longitudinal study in a Mediterranean population. Int J Cancer. 2006;118(7):1782–9.CrossRefPubMed
10.
Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control. 2000;11(7):653–62.CrossRefPubMed
11.
Boyd NF, Connelly P, Byng J, Yaffe M, Draper H, Little L, et al. Plasma lipids, lipoproteins, and mammographic densities. Cancer Epidemiol Biomarkers Prev. 1995;4(7):727–33.PubMed
12.
Boyd NF, McGuire V, Fishell E, Kuriov V, Lockwood G, Tritchler D. Plasma lipids in premenopausal women with mammographic dysplasia. Br J Cancer. 1989;59(5):766–71.CrossRefPubMedPubMedCentral
13.
Stevens VL, McCullough ML, Pavluck AL, Talbot JT, Feigelson HS, Thun MJ, et al. Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1140–7.CrossRefPubMed
14.
Knight JA, Vachon CM, Vierkant RA, Vieth R, Cerhan JR, Sellers TA. No association between 25-hydroxyvitamin D and mammographic density. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1988–92.CrossRefPubMed
15.
Pankow JS, Vachon CM, Kuni CC, King RA, Arnett DK, Grabrick DM, et al. Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. J Natl Cancer Inst. 1997;89(8):549–56.CrossRefPubMed
16.
Rosamond WD, Chambless LE, Heiss G, Mosley TH, Coresh J, Whitsel E, et al. Twenty-two-year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, 1987-2008. Circulation. 2012;125(15):1848–57.CrossRefPubMedPubMedCentral
17.
Maskarinec G, Takata Y, Pagano I, Lurie G, Wilkens LR, Kolonel LN. Alcohol consumption and mammographic density in a multiethnic population. Int J Cancer. 2006;118(10):2579–83.CrossRefPubMed
18.
Vachon CM, Kushi LH, Cerhan JR, Kuni CC, Sellers TA. Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomarkers Prev. 2000;9(2):151–60.PubMed
19.
Vachon CM, Sellers TA, Janney CA, Brandt KR, Carlson EE, Pankratz VS, et al. Alcohol intake in adolescence and mammographic density. Int J Cancer. 2005;117(5):837–41.CrossRefPubMed
20.
Funkhouser E, Waterbor JW, Cole P, Rubin E. Mammographic patterns and breast cancer risk factors among women having elective screening. South Med J. 1993;86(2):177–80.CrossRefPubMed
21.
McDonald J, Goyal A, Terry M. Alcohol Intake and Breast Cancer Risk: Weighing the Overall Evidence. Curr Breast Cancer Rep. 2013;5(3):1–14.CrossRef
22.
Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, et al. Ethnicity and Breast Cancer: Factors Influencing Differences in Incidence and Outcome. J Natl Cancer Inst. 2005;97(6):439–48.CrossRefPubMed
23.
Qi X, Ma X, Yang X, Fan L, Zhang Y, Zhang F, et al. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls. Breast Cancer Res Treat. 2010;123(2):499–506.CrossRefPubMed
24.
Dumitrescu RG, Shields PG. The etiology of alcohol-induced breast cancer. Alcohol. 2005;35(3):213–25.CrossRefPubMed
25.
Singletary KW, Gapstur SM. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA. 2001;286(17):2143–51.CrossRefPubMed
26.
Johnson RH, Chien FL, Bleyer A. Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009. JAMA. 2013;309(8):800–5.CrossRefPubMed
27.
Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 2015;313(2):165–73.CrossRefPubMed
28.
Fagherazzi G, Vilier A, Boutron-Ruault MC, Mesrine S, Clavel-Chapelon F: Alcohol consumption and breast cancer risk subtypes in the E3N-EPIC cohort. Eur J Cancer Prev. 2014.Publshed online ahead of print.
29.
Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, et al. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women’s health initiative observational study. J Natl Cancer Inst. 2010;102(18):1422–31.CrossRefPubMedPubMedCentral
30.
Boyle P. Triple-negative breast cancer: epidemiological considerations and recommendations. Ann Oncol. 2012;23 suppl 6:vi7–12.CrossRefPubMed
31.
Kabat GC, Kim M, Phipps AI, Li CI, Messina CR, Wactawski-Wende J, et al. Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women. Cancer Causes Control. 2011;22(5):775–83.CrossRefPubMedPubMedCentral
32.
del Carmen MG, Halpern EF, Kopans DB, Moy B, Moore RH, Goss PE, et al. Mammographic breast density and race. AJR Am J Roentgenol. 2007;188(4):1147–50.CrossRefPubMed
33.
Zhang J, Qiu LX, Wang ZH, Wu XH, Liu XJ, Wang BY, et al. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls. Breast Cancer Res Treat. 2010;123(2):549–55.CrossRefPubMed
34.
Vachon CM, van Gils CH, Sellers TA, Ghosh K, Pruthi S, Brandt KR, et al. Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res. 2007;9(6):217.CrossRefPubMedPubMedCentral
35.
Lissowska J, Gaudet MM, Brinton LA, Chanock SJ, Peplonska B, Welch R, et al. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int J Cancer. 2007;120(12):2696–703.CrossRefPubMed
36.
Yu L, Chen J. Association of MHTFR Ala222Val (rs1801133) polymorphism and breast cancer susceptibility: An update meta-analysis based on 51 research studies. Diagn Pathol. 2012;7:171.CrossRefPubMedPubMedCentral
37.
Izmirli M. A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk. Mol Biol Rep. 2013;40(1):625–37.CrossRefPubMed
38.
Halsted CH, Villanueva JA, Devlin AM, Chandler CJ. Metabolic interactions of alcohol and folate. J Nutr. 2002;132(8 Suppl):2367S–72.PubMed
39.
Maskarinec G, Pagano I, Lurie G, Kolonel LN. A longitudinal investigation of mammographic density: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev. 2006;15(4):732–9.CrossRefPubMed
40.
McCormack VA, Perry N, Vinnicombe SJ, Silva IS. Ethnic Variations in Mammographic Density: A British Multiethnic Longitudinal Study. Am J Epidemiol. 2008;168(4):412–21.CrossRefPubMed
41.
De Vogli R, Chandola T, Marmot MG. Negative aspects of close relationships and heart disease. Arch Intern Med. 2007;167(18):1951–7.CrossRefPubMed
42.
Razzaghi H, Troester M, Gierach G, Olshan A, Yankaskas B, Millikan R. Mammographic density and breast cancer risk in White and African American Women. Breast Cancer Res Treat. 2012;135(2):571–80.CrossRefPubMedPubMedCentral
43.
Tehranifar P, Reynolds D, Flom J, Fulton L, Liao Y, Kudadjie-Gyamfi E, et al. Reproductive and menstrual factors and mammographic density in African American, Caribbean, and white women. Cancer Causes Control. 2011;22(4):599–610.CrossRefPubMedPubMedCentral
44.
Mao Q, Gao L, Wang H, Wang Q, Zhang T. The Alcohol Dehydrogenase 1C(rs698) Genotype and Breast Cancer: A Meta-analysis. Asia Pac J Public Health. Published online before print. May 31, 2012
45.
World Cancer Research Fund/American Institute of Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR; 2007.
46.
Qureshi SA, Couto E, Hofvind S, Wu AH, Ursin G. Alcohol intake and mammographic density in postmenopausal Norwegian women. Breast Cancer Res Treat. 2012;131(3):993–1002.CrossRefPubMed
47.
48.
Yaghjyan L, Mahoney MC, Succop P, Wones R, Buckholz J, Pinney SM. Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort. Br J Cancer. 2012;106(5):996–1003. The longitudinal Fernald Community Cohort study defined low density (BI-RADS I) and high density (BI-RADS IV) as sustained low or high densities throughout the cohort’s follow-up. They found that among both pre- and postmenopausal women, ever users of alcohol were at twice the risk of having high breast density (BIRADS density IV vs. I: OR 1002.1000; 1095% CI 1001.1004-1002.1008) compared to never users.CrossRefPubMedPubMedCentral
49.
Jeon JH, Kang JH, Kim Y, Lee HY, Choi KS, Jun JK, et al. Reproductive and Hormonal Factors Associated with Fatty or Dense Breast Patterns among Korean Women. Cancer Res Treat. 2011;43(1):42–8.CrossRefPubMedPubMedCentral
50.
Cabanes A, Pastor-Barriuso R, Garcia-Lopez M, Pedraz-Pingarron C, Sanchez-Contador C, Vazquez Carrete JA, et al. Alcohol, tobacco, and mammographic density: a population-based study. Breast Cancer Res Treat. 2011;129(1):135–47.CrossRefPubMed
51.
52.
Schatzkin A, Abnet CC, Cross AJ, Gunter M, Pfeiffer R, Gail M, et al. Mendelian randomization: how it can–and cannot–help confirm causal relations between nutrition and cancer. Cancer Prev Res. 2009;2(2):104–13.CrossRef
53.
McCarty CA, Reding DJ, Commins J, Williams C, Yeager M, Burmester JK, et al. Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Breast Cancer Res Treat. 2012;133(2):785–92.CrossRefPubMedPubMedCentral
54.
Seitz HK, Pelucchi C, Bagnardi V, La Vecchia C. Epidemiology and pathophysiology of alcohol and breast cancer: Update 2012. Alcohol Alcohol. 2012;47(3):204–12.CrossRefPubMed
55.
Endogenous H, Breast Cancer Collaborative G, Key TJ, Appleby PN, Reeves GK, Roddam AW. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol. 2010;11(6):530–42.CrossRef
56.
Rinaldi S, Peeters PH, Berrino F, Dossus L, Biessy C, Olsen A, et al. IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer. 2006;13(2):593–605.CrossRefPubMed
57.
Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M, et al. The association of breast mitogens with mammographic densities. Br J Cancer. 2002;87(8):876–82.CrossRefPubMedPubMedCentral
58.
Lann D, LeRoith D. The role of endocrine insulin-like growth factor-I and insulin in breast cancer. J Mammary Gland Biol Neoplasia. 2008;13(4):371–9.CrossRefPubMed
59.
Boyd NF, Martin LJ, Yaffe MJ, Minkin S. Mammographic density: a hormonally responsive risk factor for breast cancer. J Br Menopause Soc. 2006;12(4):186–93.CrossRefPubMed
60.
Walker K, Fletcher O, Johnson N, Coupland B, McCormack VA, Folkerd E, et al. Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors. Cancer Res. 2009;69(16):6490–9.CrossRefPubMed
61.
Becker S, Kaaks R. Exogenous and endogenous hormones, mammographic density and breast cancer risk: can mammographic density be considered an intermediate marker of risk? Recent Results Cancer Res. 2009;181:135–57.CrossRefPubMed
62.
Yu H. Comment on association between insulin-like growth factor-I (IGF-I) and bone mineral density: further evidence linking IGF-I to breast cancer risk. J Clin Endocrinol Metab. 1999;84(5):1760–1.CrossRefPubMed
63.
Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006;354(3):270–82.CrossRefPubMed
64.
Hunt BR, Whitman S, Hurlbert MS. Increasing Black:White disparities in breast cancer mortality in the 50 largest cities in the United States. Cancer Epidemiol. 2014;38(2):118–23.CrossRefPubMed
65.
Andreeva VA, Unger JB, Pentz MA. Breast cancer among immigrants: a systematic review and new research directions. J Immigr Minor Health. 2007;9(4):307–22.CrossRefPubMed
66.
Terry MB, Zhang FF, Kabat G, Britton JA, Teitelbaum SL, Neugut AI, et al. Lifetime alcohol intake and breast cancer risk. Ann Epidemiol. 2006;16(3):230–40.CrossRefPubMed
67.
Gapstur SM, Potter JD, Sellers TA, Folsom AR. Increased risk of breast cancer with alcohol consumption in postmenopausal women. Am J Epidemiol. 1992;136(10):1221–31.PubMed
68.
Schatzkin A, Jones DY, Hoover RN, Taylor PR, Brinton LA, Ziegler RG, et al. Alcohol consumption and breast cancer in the epidemiologic follow-up study of the first National Health and Nutrition Examination Survey. N Engl J Med. 1987;316(19):1169–73.CrossRefPubMed
69.
Morris PG, Hudis CA, Giri D, Morrow M, Falcone DJ, Zhou XK, et al. Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res. 2011;4(7):1021–9.CrossRef
70.
Falk RT, Gentzschein E, Stanczyk FZ, Garcia-Closas M, Figueroa JD, Ioffe OB, et al. Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women. Breast Cancer Res Treat. 2012;131(1):287–94.CrossRefPubMed
71.
O’Neill JS, Elton RA, Miller WR. Aromatase activity in adipose tissue from breast quadrants: a link with tumour site. Br Med J. 1988;296(6624):741–3.CrossRef
Metadata
Title
The association of alcohol consumption with mammographic density in a multiethnic urban population
Authors
Zoe Quandt
Julie D Flom
Parisa Tehranifar
Diane Reynolds
Mary Beth Terry
Jasmine A McDonald
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2015
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-015-1094-3

Other articles of this Issue 1/2015

BMC Cancer 1/2015 Go to the issue

Debate

Can Peto’s paradox be used as the null hypothesis to identify the role of evolution in natural resistance to cancer? A critical review

Case report

Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP) associated with B-cell lymphoma: report of a rare case

Research article

DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors

Research article

Lipid peroxidation and glutathione peroxidase activity relationship in breast cancer depends on functional polymorphism of GPX1

Research article

Compounds identified by virtual docking to a tetrameric EGFR extracellular domain can modulate Grb2 internalization

Study protocol

Protocol of a multi-centre randomised controlled trial of a web-based information intervention with nurse-delivered telephone support for haematological cancer patients and their support persons
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits